Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenerative Medical Technology (RMTG) Return on Assets (2019 - 2025)

Historic Return on Assets for Regenerative Medical Technology (RMTG) over the last 7 years, with Q3 2025 value amounting to 1.47%.

  • Regenerative Medical Technology's Return on Assets rose 6600.0% to 1.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.47%, marking a year-over-year increase of 6600.0%. This contributed to the annual value of 1.66% for FY2024, which is 3400.0% down from last year.
  • Latest data reveals that Regenerative Medical Technology reported Return on Assets of 1.47% as of Q3 2025, which was up 6600.0% from 0.85% recorded in Q2 2025.
  • Regenerative Medical Technology's 5-year Return on Assets high stood at 0.01% for Q4 2022, and its period low was 7.78% during Q1 2021.
  • In the last 5 years, Regenerative Medical Technology's Return on Assets had a median value of 1.12% in 2025 and averaged 1.4%.
  • Per our database at Business Quant, Regenerative Medical Technology's Return on Assets soared by 1147000bps in 2021 and then tumbled by -24000bps in 2024.
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Return on Assets stood at 0.96% in 2021, then skyrocketed by 101bps to 0.01% in 2022, then plummeted by -15544bps to 1.29% in 2023, then decreased by -22bps to 1.58% in 2024, then rose by 7bps to 1.47% in 2025.
  • Its last three reported values are 1.47% in Q3 2025, 0.85% for Q2 2025, and 1.12% during Q1 2025.